KINEPOLIS (KIN.BR) Stock Fundamental Analysis

EBR:KIN • BE0974274061

27 EUR
+0.05 (+0.19%)
Last: Feb 12, 2026, 04:07 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to KIN. KIN was compared to 48 industry peers in the Entertainment industry. While KIN is still in line with the averages on profitability rating, there are concerns on its financial health. KIN may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year KIN was profitable.
  • KIN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: KIN reported negative net income in multiple years.
  • KIN had a positive operating cash flow in 4 of the past 5 years.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.54%, KIN is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • KIN has a Return On Equity of 23.61%. This is amongst the best in the industry. KIN outperforms 83.33% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.28%, KIN is in the better half of the industry, outperforming 77.08% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for KIN is below the industry average of 9.48%.
  • The last Return On Invested Capital (8.28%) for KIN is above the 3 year average (6.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.98%, KIN is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of KIN has declined.
  • KIN has a Operating Margin of 15.19%. This is amongst the best in the industry. KIN outperforms 91.67% of its industry peers.
  • KIN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of KIN (24.54%) is worse than 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of KIN has declined.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

  • KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, KIN has about the same amount of shares outstanding.
  • KIN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for KIN has been reduced compared to a year ago.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • KIN has an Altman-Z score of 1.49. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
  • KIN has a better Altman-Z score (1.49) than 60.42% of its industry peers.
  • KIN has a debt to FCF ratio of 5.38. This is a neutral value as KIN would need 5.38 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.38, KIN is in line with its industry, outperforming 52.08% of the companies in the same industry.
  • A Debt/Equity ratio of 2.87 is on the high side and indicates that KIN has dependencies on debt financing.
  • The Debt to Equity ratio of KIN (2.87) is worse than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.49
ROIC/WACC1.38
WACC5.98%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • KIN has a Current Ratio of 0.47. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of KIN (0.47) is worse than 87.50% of its industry peers.
  • A Quick Ratio of 0.44 indicates that KIN may have some problems paying its short term obligations.
  • KIN has a worse Quick ratio (0.44) than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 34.32% over the past year.
  • Measured over the past years, KIN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.80% on average per year.
  • The Revenue has been growing slightly by 5.38% in the past year.
  • Measured over the past years, KIN shows a small growth in Revenue. The Revenue has been growing by 0.95% on average per year.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

  • Based on estimates for the next years, KIN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.94% on average per year.
  • KIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.98% yearly.
EPS Next Y19.98%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
EPS Next 5Y14.94%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

8

4. Valuation

4.1 Price/Earnings Ratio

  • KIN is valuated correctly with a Price/Earnings ratio of 15.79.
  • Based on the Price/Earnings ratio, KIN is valued cheaply inside the industry as 93.75% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of KIN to the average of the S&P500 Index (28.18), we can say KIN is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 10.17, which indicates a very decent valuation of KIN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 85.42% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of KIN to the average of the S&P500 Index (28.01), we can say KIN is valued rather cheaply.
Industry RankSector Rank
PE 15.79
Fwd PE 10.17
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KIN indicates a somewhat cheap valuation: KIN is cheaper than 70.83% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, KIN is valued cheaper than 85.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.66
EV/EBITDA 8.03
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • KIN's earnings are expected to grow with 21.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y25.83%
EPS Next 3Y21.15%

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.40%, KIN has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.87, KIN pays a bit more dividend than its industry peers.
  • KIN's Dividend Yield is slightly below the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.4%

5.2 History

  • The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • KIN pays out 31.09% of its income as dividend. This is a sustainable payout ratio.
DP31.09%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (2/12/2026, 4:07:23 PM)

27

+0.05 (+0.19%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21
Earnings (Next)02-20
Inst Owners17.67%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap738.99M
Revenue(TTM)593.29M
Net Income(TTM)47.32M
Analysts86
Price Target46.46 (72.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.4%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.76%
PT rev (3m)-5.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.37%
EPS NY rev (3m)-5.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 15.79
Fwd PE 10.17
P/S 1.25
P/FCF 5.66
P/OCF 4.26
P/B 3.69
P/tB 32.97
EV/EBITDA 8.03
EPS(TTM)1.71
EY6.33%
EPS(NY)2.65
Fwd EY9.83%
FCF(TTM)4.77
FCFY17.67%
OCF(TTM)6.34
OCFY23.48%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.79
PEG (5Y)N/A
Graham Number16.79
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.49
F-Score8
WACC5.98%
ROIC/WACC1.38
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y19.98%
EPS Next 2Y25.83%
EPS Next 3Y21.15%
EPS Next 5Y14.94%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year104.02%
EBIT Next 3Y35.57%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%

KINEPOLIS / KIN.BR FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 4 / 10 to KIN.BR.


Can you provide the valuation status for KINEPOLIS?

ChartMill assigns a valuation rating of 8 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of KINEPOLIS (KIN.BR) stock?

The Price/Earnings (PE) ratio for KINEPOLIS (KIN.BR) is 15.79 and the Price/Book (PB) ratio is 3.69.


Is the dividend of KINEPOLIS sustainable?

The dividend rating of KINEPOLIS (KIN.BR) is 3 / 10 and the dividend payout ratio is 31.09%.